Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Cash Flow-to-Debt Ratio
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥133.43 Million could theoretically repay 0% of its total liabilities (CN¥2.97 Billion) in one year. See free cash flow generation of Zhejiang CONBA Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. Also explore Zhejiang CONBA Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Zhejiang CONBA Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see market value of Zhejiang CONBA Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥942.61 Million | CN¥2.83 Billion | ▼ -1.7% |
| 2024 | 0.34x | CN¥1.01 Billion | CN¥2.99 Billion | ▲ +46.6% |
| 2023 | 0.23x | CN¥898.64 Million | CN¥3.89 Billion | ▼ -27.9% |
| 2022 | 0.32x | CN¥1.16 Billion | CN¥3.61 Billion | ▲ +22.4% |
| 2021 | 0.26x | CN¥889.94 Million | CN¥3.40 Billion | ▼ -17.7% |
| 2020 | 0.32x | CN¥1.25 Billion | CN¥3.93 Billion | ▲ +69.0% |
| 2019 | 0.19x | CN¥925.50 Million | CN¥4.92 Billion | ▲ +69.7% |
| 2018 | 0.11x | CN¥545.78 Million | CN¥4.92 Billion | ▼ -44.3% |
| 2017 | 0.20x | CN¥712.27 Million | CN¥3.58 Billion | ▼ -17.7% |
| 2016 | 0.24x | CN¥969.71 Million | CN¥4.01 Billion | ▲ +45.7% |
| 2015 | 0.17x | CN¥831.26 Million | CN¥5.00 Billion | ▼ -21.2% |
| 2014 | 0.21x | CN¥617.43 Million | CN¥2.93 Billion | ▲ +66.8% |
| 2013 | 0.13x | CN¥235.36 Million | CN¥1.86 Billion | ▲ +7.9% |
| 2012 | 0.12x | CN¥245.76 Million | CN¥2.10 Billion | ▼ -16.1% |
| 2011 | 0.14x | CN¥188.36 Million | CN¥1.35 Billion | ▼ -17.1% |
| 2010 | 0.17x | CN¥125.93 Million | CN¥747.34 Million | ▼ -14.2% |
| 2009 | 0.20x | CN¥153.39 Million | CN¥780.76 Million | ▲ +29.5% |
| 2008 | 0.15x | CN¥98.56 Million | CN¥649.60 Million | ▲ +31.5% |
| 2007 | 0.12x | CN¥79.98 Million | CN¥693.32 Million | ▲ +1.8% |
| 2006 | 0.11x | CN¥71.20 Million | CN¥628.20 Million | ▼ -46.0% |
| 2005 | 0.21x | CN¥117.65 Million | CN¥560.55 Million | ▲ +33.5% |
| 2004 | 0.16x | CN¥65.47 Million | CN¥416.37 Million | ▼ -19.2% |
| 2003 | 0.19x | CN¥66.64 Million | CN¥342.22 Million | — |